Cardiovascular Medicine

Report Highlights

• The Global Market For Cardiovascular Diagnostics And Therapy Increased From $111 Billion In 2006 To An Estimated $119.8 Billion In 2007. It Should Reach $192.4 Billion Through 2012, A Compound Annual Growth Rate (Cagr) Of 9.9%.
• The Cardiovascular Diagnostics Market Represents One Of The Largest Sectors In The Diagnostics Industry Chiefly Due To The High Prevalence Rate Of And Mortality From Cardiovascular Disease.
• Of The Cardiovascular Diagnostics, Devices And Drugs Markets, The Drugs Market Is The Largest, Worth An Estimated $82.4 Billion In 2007 And Expected To Reach $121.6 Billion In 2012.

Introduction

This Market Research Report Is An Update Of Bcc's Original Report On The Topic, Published In 2001. Bcc's Goal In Conducting This Study Is To Provide An Overview Of The Current And Potential Aspects Of The Global Market For Cardiovascular Drugs, Devices, And Diagnostics In The Pharmaceutical And Biotechnology Industries. The Report Determines The Market Size, Market Leaders, And Factors Affecting The Market Of Cardiovascular Drugs, Devices, And Diagnostics.

The Overview Of Types Of Cardiovascular Diseases And Their Prevalence Is Examined Along With Sales Figures Over The 5-Year Period From 2007 To 2012. Companies Selling Drugs, Devices, And Diagnostics Are Profiled; The Factors Affecting Markets For These Products, And How Those Markets Are Likely To Change, Are Analyzed. Revenues Have Been Broken Down By The Type Of Drug Products, Devices Implanted, And Diagnoses Performed.

Our Key Objective Is To Present A Comprehensive Analysis Of The Current Market And The Future Direction Of Cardiovascular Drugs, Devices, And Diagnostics, With An Emphasis On Newer Products.

Scope Of Study

This Report Contains:

• Descriptions Of Various Types Of Cardiovascular Diagnostics Such As In Vitro Tests And In Vivo Imaging Techniques, Devices Such As Drug Eluting Stents, And Drugs Such As Pfizer's Blockbuster Lipitor
• The Current Market Status Of Cardiovascular Diagnostics, Devices And Drugs, Along With Trends And Forecasts For Growth Over The Next 5 Years
• Technological Issues Including The Latest Developments And A Thorough Patent Analysis
• Analysis Of The Cardiovascular Diagnostics, Devices And Drugs Industry, Both From A Market And Application Perspective
• Information About The Major Players In Each Market, Including Medtronic And Boston Scientific In Devices, Sanofi-Aventis And Bms In Drugs, And Abbott In Devices.

Information Sources

A Comprehensive Literature Search Was Conducted. The Literature Included Technical Newsletters And Journals, As Well As Many Other Sources. The Data Was Collected Through Interviews And Correspondence With Various Pharmaceutical/Biotechnical Experts. Projections Were Based On Estimates Such As The Current Number Of End Users, Potential End Users, Likely Unit Prices, Rates Of Consumption, And Market Trends.

Bcc Surveyed Many Companies To Obtain Data For This Study. Included Were Manufacturers And End Users Of The Pharmaceutical Drugs Through Contract Manufacturing/Research. Data Were Gathered From The Industries; Spoke With Officials Or Physicians Of These Industries; And Consulted Newsletters, Company Literature, Product Literature, A Host Of Technical Articles, Journals, Indexes, And Abstracts. Exhaustive Investigations Of Databases By Key Terminology Were Done. In Addition, Data Were Compiled Data From Current Financial And Trade Information And Government Sources.

Analyst Credentials

Shalini Shahani Holds A Masters Degree In Pharmaceutical Chemistry. Among The Research Topics She Has Covered Are Studies On Compounds Of Potential Pharmaceutical Interest, Including Ibuprofen And 2-Naphthyl Acetic Acid. Shahani Was Awarded A Gold Medal By The Prime Minister Of India For Her Work And Has Worked With Top Companies In India And In The U.S. She Has Authored Several Market Research Reports For Bcc Research On Various Topics Within The Chemical And Pharmaceutical Industries, Including Reagents For Chromatography, Spectroscopy, Advanced Drug Delivery, Contract Pharmaceutical Manufacturing, And Chiral Technology.

• Chapter 1 - Summary
  • The Cardiovascular Diagnostic, Drug, And Device Markets
  • Summary Table: Worldwide Revenue Of Cardiovascular Diagnostics, Drugs, And Devices, Through 2012 ($ Billions)
  • Summary Figure: Worldwide Revenue Of Cardiovascular Diagnostics, Drugs, And Devices, 2005-2012 ($ Billions)
• Chapter 2 - Overview
  • What Is Cardiovascular (Cv) Disease?
  • Causes Of Cardiovascular Disease
  • Causes Of Cardiovascular Disease (Continued)
  • Cardiovascular Diagnostics
  • Cardiovascular Medicine
  • Cardiovascular Devices
• Chapter 3 - Cardiovascular Diseases
  • Diseases Of The Heart (Cardio) And Diseases Of The Blood Vessels (Vascular)
  • Diseases Of The Heart
  • Coronary Artery Disease (Cad)
  • Coronary Heart Disease (Chd)
  • Cardiomyopathy
  • Valvular Heart Disease
  • Pericardial Disease
  • Congenital Heart Disease
  • Heart Failure
  • Disease Of Blood Vessels
  • Arteriosclerosis And Atherosclerosis
  • High Blood Pressure
  • Stroke
  • Aneurysm
  • Peripheral Arterial Disease And Claudication (Pad)
  • Vasculitis
  • Venous Incompetence
  • Venous Thrombosis
  • Varicose Veins
  • Lymphedema
  • Epidemiology Of Cardiovascular Disease
  • Global Distribution Pattern In 2004
  • Age
  • Gender
  • Role Of Risk Factors
  • Risk Factors
  • Psychological And Social Factors
  • Prevention Of Cardiovascular Disease
• Chapter 4 - Prevalance Of Cardiovascular Diseases
  • Major Cause Of Death
  • The Epidemiological Transition
  • Prevalence Of Heart Disease In Various Categories
  • Age
  • Gender
  • Race/ Ethnicity
  • Education
  • Table 1 Prevalence Of Stroke, Myocardial Infarction, And Angina Pectoris By Various Categories, 2005
  • Figure 1 Prevalence Of Stroke, Myocardial Infarction, And Angina Pectoris By Age Group, 2005 (%)
  • Figure 2 Prevalence Of Stroke, Myocardial Infarction, And Angina Pectoris By Gender, 2005 (%)
  • Figure 3 Prevalence Of Stroke, Myocardial Infarction, And Angina Pectoris By Race/Ethinicity, 2005 (%)
  • Figure 4 Prevalence Of Stroke, Myocardial Infarction, And Angina Pectoris By Education 2005 (%)
  • Prevalence Of Cardiovascular Diseases In The U.S.
  • Table 2 Prevalence Of Cardiovascular Diseases In U.S., 2005 (Million People)
  • Figure 5 Prevalence Of Cardiovascular Diseases In The U.S., 2005 (Million People)
  • Cost Of Cardiovascular Diseases In The U.S.
  • Table 3 Cost Of Cardiovascular Diseases In U.S. Through 2012 ($ Billions)
  • Figure 6 Cost Of Cardiovascular Diseases In The U.S., 2005-2012 ($ Billions)
  • Prevalence And Cost Of Cardiovascular Diseases In Europe
  • Mortality Due To Cardiovascular Diseases
  • U.S.
  • Table 4 Mortality Due To Cardiovascular Diseases In The U.S., 2005 (%)
  • Table 4 (Continued)
  • Figure 7 Mortality Due To Cardiovascular Diseases In The U.S. 2005 (%)
  • Europe
  • Table 5 Mortality Due To Cardiovascular Diseases In Europe, 2005 (%)
  • Figure 8 Mortality Due To Cardiovascular Diseases In The U.S., 2005 (%)
• Chapter 5 - Regulatory Issues
  • Cardiovascular Drugs Approved By Fda
  • Table 6 Cardiovascular Drugs Approved By Fda, 2002-2007*
  • Figure 9 Cardiovascular Drugs Approved By Fda, 2002-2007*
  • Cardiovascular Devices Approved By The Fda
  • Table 7 Cardiovascular Devices Approved By The Fda, 2002-2007*
  • Table 7 (Continued)
  • Table 7 (Continued)
  • Figure 10 Cardiovascular Devices Approved By The Fda 2002-2007*
  • Cardiovascular Drugs Recalled By Fda
  • Table 8 Cardiovascular Drugs Recalled By The Fda, 2002-2007*
  • Cardiovascular Devices Recalled By Fda
  • Table 9 Cardiovascular Devices Recalled By The Fda, 2002-2007*
  • Table 9 (Continued)
  • Figure 11 Cardiovascular Devices Recalled By Fda, 2002-2007*
  • Figure 11 (Continued)
  • New Drug Applications
  • New Drug Applications (Continued)
  • New Drug Applications (Continued)
• Chapter 6 - Cardiovascular Diagnostics
  • Diagnostics Definition
  • In Vitro Diagnostic
  • Biomarkers
  • Aspartate Aminotransferase (Ast/Got)
  • Lactate Dehydrogenase And Its Isoenzyme Ld
  • Creatine Kinase (Ck) And Its Isoenzyme Mb
  • Myoglobin
  • Cardiac Troponins
  • Reasons Behind The Replacement Of Ckmb With Troponins
  • Myoglobin/Carbonic Anhydrase Iii Ratio
  • Glycogen Phosphorylase Isoenzyme Bb
  • Heart Type Fatty Acid Binding Protein
  • Comparison Between Ctnt And Ctnl
  • Natriuretic Peptides As Cardiac Biomarkers
  • Table 10 Nt-Probnp In Acute Situations
  • Table 11 Nt-Probnp In Primary Care Setting
  • Point-Of-Care Testing
  • Need For The Poct
  • Table 12 Advantages Of Point Of Care Testing
  • Table 13 Disadvantages Of Point Of Care Testing
  • Past, Present, And Future Of Point-Of-Care Testing
  • Past
  • Present
  • Future
  • Determining Whether To Use Poc Cardiac Testing In The Ed
  • Considerations Of Turnaround Times
  • The Importance Of Quantitative Results
  • Concerns About Standardization
  • Venues For Poc Testing
  • Table 14 Venues For Poc Testing
  • In Vivo Diagnostics
  • Echocardiography
  • Need Of The Echocardiography
  • Table 15 Types Of Echocardiograms
  • Ultrasound
  • Table 16 Types Of Doppler Ultrasound
  • Advantages Of Ultrasound
  • Mri
  • Need Of Mri Scan
  • Positron Emission Tomography
  • Computed Tomography
  • Electron-Beam Computed Tomography (Ebct Or Ultrafast Ct)
  • Electron-Beam Computed (Continued)
• Chapter 7 - Cardiovascular Therapy
  • Cardiovascular Drugs
  • Anti-Anginal Agents
  • Table 17 Commonly Used Anti-Anginal Agents
  • Anti-Arrhythmic Agents
  • Table 18 Commonly Used Anti-Arrhythmic Agents
  • Anti-Hypertensive Drugs
  • Table 19 Commonly Used Anti-Hypertensive Agents
  • Anti-Thrombotic Agents
  • Blood Lipid Lowering Agents
  • Table 20 Commonly Used Blood Lipid Lowering Agents
  • Drugs Used To Treat Congestive Heart Failure
  • Table 21 Commonly Used Drugs To Treat Congestive Heart Failure
  • Cardiovascular Devices
  • Pacemakers
  • Table 22 Pacemakers
  • Defibrillators
  • Manual External Defibrillators
  • Manual Internal Defibrillator
  • Automated External Defibrillator
  • Semi-Automated External Defibrillator
  • Implantable Cardioverter Defibrillator
  • Drug-Eluting Stents (Des)
  • Catheters
  • Valves
  • Mechanical Heart Valve
  • Biological Heart Valve
  • Ventricular Assist Device
  • Guidewires
  • Artificial Heart
  • Cardiac Resynchronization Therapy
  • Cardiac Resynchronization Therapy
  • Cardiac Resynchronization Therapy Devices
  • Difference Between Biventricular Pacemaker And Standard Pacemaker
  • Use Of Crt
  • Benefits Of Crt
  • Potential Risks With Biventricular Pacemakers
• Chapter 8 - Industry Structure
  • Cardiovascular Diagnostics
  • Cardiac Biomarkers
  • Table 23 Present Cardiac Marker Testing
  • Market Shares For Companies Providing Biomarker Tests
  • Table 24 Market Share Of Companies Providing Biomarker Tests, 2006 (%)
  • Figure 12 Market Share Of Companies Providing Biomarker Tests, 2006 (%)
  • Effect Of Poct On The Growth Of Cardiac Biomarker Testing In Laboratory
  • Point Of Testing For Cardiac Biomarkers
  • Table 25 Present Point-Of-Care Testing For Cardiac Biomarkers
  • Market Shares For Companies Providing Biomarker Tests
  • Table 26 Market Share Of Companies Providing Point-Of-Care Testing For Cardiac Biomarkers, 2006 (%)
  • Figure 13 Market Share Of Companies Providing Point-Of Care Testing For Cardiac Biomarkers, 2006 (%)
  • Factors Influencing The Growth Of Point-Of-Care Testing
  • Challenges For The Manufacturers
  • In-Vivo Diagnostics
  • Table 27 Present Imaging Systems For In-Vivo Diagnosis
  • Market Shares For Companies Providing In-Vivo Diagnostics
  • Table 28 Market Share Of Companies Providing In-Vivo Diagnostics, 2006 (%)
  • Figure 14 Market Share Of Companies Providing In-Vivo Diagnostics, 2006 (%)
  • Factors Affecting The Growth Of Cardiac Imaging Or In Vivo Diagnostics
  • Cardiovascular Drugs
  • Anti-Anginal Agents
  • Table 29 Global Market Leaders Of Anti-Anginal Agents
  • Market Shares For Anti-Anginal Agents
  • Table 30 Market Share Of Companies Manufacturing Anti-Anginal Agents, 2006 (%)
  • Figure 15 Market Share Of Companies Manufacturing Anti-Anginal Agents, 2006 (%)
  • Anti-Arryhthmic Agents
  • Table 31 Global Market Leaders Of Anti-Arrhythmic Agents
  • Market Shares For Anti-Arrhythmic Agents
  • Table 32 Market Share Of Companies Manufacturing Anti-Arrhythmic Agents, 2006 (%)
  • Figure 16 Market Share Of Companies Manufacturing Anti-Arrhythmic Agents, 2006 (%)
  • Anti-Hypertensive Agents
  • Table 33 Global Market Leaders Of Anti-Hypertensive Agents
  • Market Shares For Anti-Hypertensive Agents
  • Table 34 Market Share Of Companies Manufacturing Anti-Hypertensive Agents, 2006 (%)
  • Figure 17 Market Share Of Companies Manufacturing Anti-Hypertensive Agents, 2006 (%)
  • Anti-Thrombotic Agents
  • Table 35 Global Market Leaders Of Anti-Thrombotic Agents
  • Market Shares For Anti-Thrombotic Agents
  • Table 36 Market Share Of Companies Manufacturing Anti-Thrombotic Agents, 2006 (%)
  • Figure 18 Market Share Of Companies Manufacturing Anti-Thrombotic Agents, 2006 (%)
  • Blood Lipid Lowering Agents
  • Table 37 Global Market Leaders Of Blood Lipid Lowering Agents
  • Market Shares For Blood Lipid Lowering Agents
  • Table 38 Market Share Of Companies Manufacturing Blood Lipid Lowering Agents, 2006 (%)
  • Figure 19 Market Share Of Companies Manufacturing Blood Lipid Lowering Agents, 2006 (%)
  • Drugs Treating Congestive Heart Failure
  • Table 39 Global Market Leaders Of Drugs Treating Congestive Heart Failure
  • Market Shares For Drugs Treating Congestive Heart Failure
  • Table 40 Market Share Of Companies Manufacturing Drugs Treating Congestive Heart Failure, 2006 (%)
  • Table 40 (Continued)
  • Figure 20 Market Share Of Companies Manufacturing Drugs Treating Congestive Heart Failure, 2006 (%)
  • Factors Affecting The Sales Of Cardiovascular Drugs
  • Price Control/ Price Pressure
  • Expiration Of Patents
  • Major Factors For Future Growth
  • Life Expectancy
  • Access Of Senior Citizens To Prescription Drugs
  • Patent Protection
  • Drugs Portfolio Management
  • Significant Potential Of Developing Countries
  • Cardiovascular Devices
  • Pacemakers
  • Table 41 Global Market Leaders Of Manufacturers Of Pacemakers
  • Market Shares Of Companies Manufacturing Pacemakers
  • Table 42 Market Share Of Companies Manufacturing Pacemakers, 2006 (%)
  • Figure 21 Market Share Of Companies Manufacturing Pacemakers, 2006 (%)
  • Cardioverter Defibrillators
  • Table 43 Global Market Leaders Of Manufacturers Of Conventional Cardioverter Defibrillators
  • Table 44 Global Market Leaders Of Manufacturers Of Crt-Defibrillators
  • Market Shares Of Companies Manufacturing Conventional Cardioverter Defibrillators
  • Table 45 Market Share Of Companies Manufacturing Conventional Cardioverter Defibrillators, 2006 (%)
  • Figure 22 Market Share Of Companies Manufacturing Conventional Cardioverter Defibrillators, 2006 (%)
  • Market Shares Of Companies Manufacturing Crt-Defibrillators
  • Table 46 Market Share Of Companies Manufacturing Crt-Defibrillators, 2006 (%)
  • Figure 23 Market Share Of Companies Manufacturing Crt-Defibrillators, 2006 (%)
  • Drug Eluting Stents
  • Table 47 Global Market Leaders Of Manufacturers Of Drug Eluting Stents
  • Market Shares Of Companies Manufacturing Drug Eluting Stents
  • Table 48 Market Share Of Companies Manufacturing Drug Eluting Stents, 2006 (%)
  • Figure 24 Market Share Of Companies Manufacturing Drug Eluting Stents, 2006 (%)
  • Catheters
  • Table 49 Global Market Leaders Of Manufacturers Of Catheters
  • Table 49 (Continued)
  • Market Shares Of Companies Manufacturing Catheters
  • Table 50 Market Share Of Companies Manufacturing Catheters, 2006 (%)
  • Figure 25 Market Share Of Companies Manufacturing Catheters, 2006 (%)
  • Heart Valves
  • Table 51 Global Market Leaders Of Manufacturers Of Heart Valves
  • Market Shares Of Companies Manufacturing Heart Valves
  • Table 52 Market Share Of Companies Manufacturing Heart Valves, 2006 (%)
  • Figure 26 Market Share Of Companies Manufacturing Heart Valves, 2006 (%)
  • Ventricular Assist Device
  • Table 53 Global Market Leaders Of Manufacturers Of Ventricular Assist Devices
  • Market Shares Of Companies Manufacturing Ventricular Assist Devices
  • Table 54 Market Share Of Companies Manufacturing Ventricular Assist Devices, 2006 (%)
  • Figure 27 Market Share Of Companies Manufacturing Ventricular Assist Devices, 2006 (%)
  • Guide Wires
  • Table 55 Global Market Leaders Of Manufacturers Of Guide Wires
  • Market Shares Of Companies Manufacturing Guidewires
  • Table 56 Market Share Of Companies Manufacturing Guidewires, 2006 (%)
  • Figure 28 Market Share Of Companies Manufacturing Guidewires, 2006 (%)
  • Factors Affecting The Sales Of Cardiovascular Devices
  • Aging Baby-Boomers
  • Regulation
  • Competitive Landscape Of Technology
  • Shortening Of Patent Lives
  • Business Taxes
• Chapter 9 - Market Analysis Of Cardiovascular Diagnostics
  • Cardiac Biomarkers
  • Table 57 Global Sales Of Cardiac Biomarkers, Through 2012 ($ Millions)
  • Figure 29 Global Sales Of Cardiac Biomarkers, 2005-2012 ($ Millions)
  • Cardiac Marker Testing By Type
  • Table 58 Estimated Worldwide Market For Cardiac Marker Testing By Type, Through 2012 ($ Millions)
  • Figure 30 Global Sales Of Cardiac Biomarkers, By Type, 2005-2012 ($ Millions)
  • Point-Of-Care Testing
  • Table 59 Global Sales Of Point-Of-Care Testing, Through 2012 ($ Millions)
  • Figure 31 Global Sales Of Point-Of-Care Testing, 2005-2012 ($ Millions)
  • In Vivo Diagnostics
  • In Vivo Diagnostics (Continued)
  • Table 60 Global Sales Of In-Vivo Diagnostics, Through 2012 ($ Millions)
  • Figure 32 Global Sales Of In Vivo Diagnostics. 2005-2012 ($ Millions)
  • Total Market Shares Of Cardiovascular Diagnostics Worldwide
  • Table 61 Worldwide Market Share Of Cardiovascular Diagnostics, 2006 (%)
  • Figure 33 Worldwide Market Share Of Cardiovascular Diagnostics, 2006 (%)
• Chapter 10 - Market Analysis Of Cardiovascular Drugs
  • Anti-Anginal Agents
  • Table 62 Global Sales Of Anti-Anginal Drugs, Through 2012 ($ Billions)
  • Figure 34 Global Sales Of Anti-Anginal Drugs, 2005-2012($ Billions)
  • Anti-Arrhythmic Agents
  • Table 63 Global Sales Of Anti-Arrhythmic Drugs, Through 2012 ($ Billions)
  • Figure 35 Global Sales Of Anti-Arrhythmic Drugs, 2005-2012 ($ Billions)
  • Anti-Hypertensive Agents
  • Table 64 Global Sales Of Anti-Hypertensive Drugs, Through 2012 ($ Billions)
  • Figure 36 Global Sales Of Anti-Hypertensive Drugs, 2005-2012 ($ Billions)
  • Anti-Thrombotic Agents
  • Table 65 Global Sales Of Anti-Thrombotic Drugs, Through 2012 ($ Billions)
  • Figure 37 Global Sales Of Anti-Thrombotic Drugs, 2005-2012 ($ Billions)
  • Blood Lipid Lowering Agents
  • Table 66 Global Sales Of Blood Lipid Lowering Drugs, Through 2012 ($ Billions)
  • Figure 38 Global Sales Of Blood Lipid Lowering Drugs, 2005-2012 ($ Billions)
  • Drugs Used To Treat Congestive Heart Failure
  • Table 67 Global Sales Of Drugs Used To Treat Congestive Heart Failure, Through 2012 ($ Billions)
  • Figure 39 Global Sales Of Drugs Used To Treat Congestive Heart Failure, 2005-2012 ($ Billions)
  • Total Worldwide Market Shares Of Cardiovascular Drugs
  • Table 68 Market Share Of Cardiovascular Drugs, 2006 (%)
  • Figure 40 Market Share Of Cardiovascular Drugs, 2006 (%)
• Chapter 11 - Cardiovascular Devices Market Analysis
  • Pacemakers
  • Table 69 Global Sales Of Pacemakers, Through 2012 ($ Millions)
  • Figure 41 Global Sales Of Pacemakers, 2005-2012 ($ Millions)
  • Implantable Cardioverter Defibrillators
  • Table 70 Global Sales Of Conventional Implantable Cardioverter Devices, Through 2012 ($ Millions)
  • Figure 42 Global Sales Of Implantable Cardioverter Devices, 2005-2012 ($ Millions)
  • Table 71 Global Sales Of Crt-Defibrillators, Through 2012 ($ Millions)
  • Figure 43 Global Sales Of Implantable Crt-Defibrillators, 2005-2012 ($ Millions)
  • Drug Eluting Stents (Des) And Grafts
  • Drug Eluting Stents (Des) And Grafts (Continued)
  • Table 72 Global Sales Of Drug Eluting Stents And Grafts, Through 2012 ($ Millions)
  • Figure 44 Global Sales Of Drug Eluting Stents And Grafts, 2005-2012 ($ Millions)
  • Catheters
  • Table 73 Global Sales Of Catheters, Through 2012 ($ Millions)
  • Figure 45 Global Sales Of Catheters, 2005-2012 ($ Millions)
  • Heart Valves
  • Table 74 Global Sales Of Heart Valves, Through 2012 ($ Millions)
  • Figure 46 Global Sales Of Heart Valves, Through 2012 ($ Millions)
  • Ventricular Assist Devices
  • Table 75 Global Sales Of Ventricular Assist Devices, Through 2012 ($ Millions)
  • Figure 47 Global Sales Of Ventricular Assist Devices, 2005-2012 ($ Millions)
  • Guidewires
  • Table 76 Global Sales Of Guidewires, Through 2012 ($ Millions)
  • Figure 48 Global Sales Of Guidewires, 2005-2012 ($ Millions)
  • Artificial Heart
  • Total Market Shares Of Cardiovascular Devices Worldwide
  • Table 77 Market Share Of Cardiovascular Devices, 2006 (%)
  • Figure 49 Market Share Of Cardiovascular Devices, 2006 (%)
• Chapter 12 - New Developments/ Technological Innovations
  • Diagnostics
  • Siemens Medical Solutions
  • Neurosonix Ltd
  • University Hospital Mannheim And Ospedali Riuniti Di Bergamo
  • Sorin
  • Philips
  • Topspin Medical
  • Sonosite, Inc.
  • Datascope Corporation
  • Response Biomedical
  • Astrazeneca
  • Bms & Pfizer
  • Decode Genetics
  • Encysive Pharmaceuticals Inc.
  • Epix Pharmaceuticals, Inc.
  • Lexicon Pharmaceuticals
  • Merck & Company
  • Momenta Pharmaceuticals, Inc.
  • Nile Therapeutics, Inc.
  • Pharmacopeia
  • Sanofi-Aventis
  • Takeda Pharmaceutical
  • University Of North Carolina
  • Devices
  • Abbott
  • Abiomed, Inc.
  • Ats Medical
  • Cardiatis
  • Cryocath Technologies, Inc.
  • Cryocor, Inc.
  • Edward Lifesciences
  • Medtronic, Inc.
  • Methodist Debakey Heart Center
  • St. Jude Medical, Inc.
  • Stem Cells And Heart Disease
  • Stem Cells And Heart Disease (Continued)
• Chapter 13 - Patent Analysis $ 578.
  • Total Patents
  • Patents By Year
  • Table 78 Total Number Of Significant Patents, 2005-2007
  • Figure 50 Number Of Patents, 2005-2007
  • Figure 51 Number Of Patents, Share By Year, 2005-2007 (%)
  • Patents By Country
  • Table 79 Total Number Of Patents By Country, 2005-2007
  • Figure 52 Total Number Of Patents By Country, 2005-2007
  • Diagnostics Patents
  • Patents By Year
  • Table 80 Patents For Diagnostics By Year, 2005-2007
  • Figure 53 Patents For Diagnostics By Year, 2005-2007
  • Patents By Country
  • Table 81 Patents By Country For Diagnostics, 2005-2007
  • Figure 54 Patents By Country For Diagnostics, 2005-2007
  • Patents By Company
  • Table 82 Number Of Patents By Company For Diagnostics
  • Table 82 (Continued)
  • Figure 55 Total Number Of Patents By Company For Diagnostics, 2005-2007
  • Patents By Assignee
  • Table 83 Number Of Patents By Assignee For Diagnostics, 2005-2007
  • Figure 56 Number Of Patents By Assignee For Diagnostics, 2005-2007
  • Drug Patents
  • Patents By Country
  • Table 84 Patents By Country For Drugs, 2005-2007
  • Figure 57 Patents By Country For Drugs, 2005-2007
  • Patents By Company
  • Table 85 Number Of Patents By Company For Drugs, 2005-2007
  • Table 85 (Continued)
  • Figure 58 Total Number Of Patents By Company For Drugs, 2005-2007
  • Patents By Assignee
  • Table 86 Number Of Patents By Assignee For Devices, 2005-2007
  • Figure 59 Number Of Patents By Assignee For Drugs, 2005-2007
  • Device Patents
  • Patents By Year
  • Table 87 Patents For Devices By Year, 2005-2007
  • Figure 60 Patents For Devices By Year, 2005-2007
  • Patents By Country
  • Table 88 Patents By Country For Devices, 2005-2007
  • Figure 61 Patents By Country For Devices, 2005-2007
  • Patents By Company
  • Table 89 Number Of Patents By Company For Devices, 2005-2007
  • Table 89 (Continued)
  • Figure 62 Total Number Of Patents By Company For Devices, 2005-2007
  • Patents By Assignee
  • Table 90 Number Of Patents By Assignee For Devices, 2005-2007
  • Figure 63 Number Of Patents By Assignee For Devices, 2005-2007
• Chapter 14 - Company Profiles For Diagnostics
  • Abbott Laboratories Inc.
  • Axis-Shield Plc
  • Bayer Ag
  • Beckman Coulter Inc.
  • Biomrieux Inc.
  • Biosite Incorporated
  • Biosound Esaote Inc.
  • Cambridge Heart Inc.
  • Cholestech
  • Covidien
  • Dade Behring Inc.
  • Deltex Medical Group Plc
  • Epix Pharmaceuticals, Inc.
  • Ep Medsystems
  • Fonar Corporation
  • Ge Healthcare
  • Hypertension Diagnostic Inc.
  • Inverness Medical Innovations, Inc
  • Mallinckrodt
  • Medison America Inc.
  • Mortara Instrument Inc.
  • Olympus America Inc.
  • Ortho-Clinical Diagnostics, Inc. (Johnson & Johnson Co.)
  • Philips Medical System
  • Premd Inc.
  • Response Biomedical Corp.
  • Roche Holding
  • Siemens
  • Sonosite
  • Sonosite (Continued)
• Chapter 15 - Company Profiles For Drugs
  • Abbott Laboratories Inc.
  • Astrazeneca Plc
  • Bayer Healthcare Pharmaceuticals Inc.
  • Biovail Corporation
  • Boehringer Ingelheim
  • Bristol-Myers Squibb Company
  • Cv Therapeutics Inc.
  • Hoffman-La Roche Inc.
  • Krka Group
  • Les Laboratories Servier
  • Merck & Co. Inc.
  • Merck Kgaa
  • Novartis Ag
  • Pfizer Inc.
  • Sanofi Aventis
  • Schering Plough
  • Solvay S.A.
  • Ucb
  • Wyeth
  • Zentiva N.V.
• Chapter 16 - Company Profiles For Devices
  • Ambu International As
  • Angiodynamics Inc.
  • Asahi Intecc Co., Ltd.
  • Ats Medical Inc.
  • Bacchus Vascular
  • Bioheart Inc.
  • Biosensor International Group
  • Boston Scientific Corporation
  • Cardima Inc.
  • Conor Medsystems, Llc
  • Cook Group
  • Cordis Corporation (Johnson &johnson Co.)
  • Corevalve
  • C.R. Bard Inc.
  • Cryocath
  • Cryocor
  • Datascope Corp.
  • Edward Lifesciences Corp.
  • Goodman Co. Ltd.
  • Hansen Medical
  • Hospira
  • Japan Lifeline
  • Medtronic
  • Merit Medical System Inc.
  • Nmt Medical Inc.
  • Possis Medical
  • Sorin Group
  • St.Jude Medical
  • Terumo
  • Thoratec
  • Vascular Solutions Inc.
  • World Heart Corp.
  • Zoll Medical Inc.
• Chapter 17 - Appendix
  • Table 91 Acronyms
  • Table 91 (Continued)
  • Table 91 (Continued)